Global $8.2Bn Oligonucleotide Synthesis Market by 2024 – Opportunities in Emerging Asian Markets

NEXT STORY
Nabriva Therapeutics Announces Submission of Marketing Authorization Application for Lefamulin to Treat Community-Acquired Pneumonia in Adults by European Medicines Agency
PREV STORY
EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Monalizumab to advance to Phase III in head and neck cancer

author_avatar
NASDAQ Market News

Six Prime Healthcare Hospitals Select Critical Alert Nurse Call System to Improve Clinical Workflow & Patient-To-Caregiver Communications

JACKSONVILLE, Fla., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Critical Alert Systems, a leading provider ...

author_avatar
NASDAQ Market News

New Roche data for Evrysdi show improved motor function in pre-symptomatic babies after one year and confirm safety profile in previously treated people with spinal muscular atrophy (SMA)

author_avatar
NASDAQ Market News